Regulatory Science: FDA Gets Help From NIH, But Is It Enough? 

The Food and Drug Administration is turning to the National Institutes of Health in its quest for fresh intellectual firepower to keep its regulatory science upgrade program moving ahead. [Editor's note: This story, including the headline, has been modified to correct figures related to funding for the Critical Path initiative.